<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02946424</url>
  </required_header>
  <id_info>
    <org_study_id>SCIMS Statin</org_study_id>
    <nct_id>NCT02946424</nct_id>
  </id_info>
  <brief_title>Simvastatin to Prevent SCI-Induced Bone Loss</brief_title>
  <official_title>Simvastatin to Improve Bone Health in SCI: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Craig Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Craig Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a double blind, randomized, placebo -controlled clinical trial with the primary goal
      of determining the osteogenic benefits of simvastatin in acute SCI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will test if a 1- year course of simvastatin (40 mg daily) will prevent bone
      loss compared to placebo in the first year following SCI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in knee bone mineral density</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>assessed by DXA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in bone volume</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>quantitative CT scan of the knee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in mood</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>Patient Health Questionnaire-9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pain</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>International Spinal Cord Injury Basic Pain Data Set</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with life</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>Satisfaction with Life Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in community reintegration</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>Craig Handicap and Assessment Reporting Technique-Short Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in motor score</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>assessed by ISNCSCI exam</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in tibial bone strength</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>assessed by finite element analysis of quantitative CT scan of the knee</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in bone formation</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>assessed by circulating osteocalcin level</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in bone resorption</measure>
    <time_frame>baseline and 12 months</time_frame>
    <description>assessed by circulating c-telopeptide level</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Simvastatin treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Simvastatin for one year time period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo for one year time period</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Capsule</intervention_name>
    <description>12 month course of daily placebo</description>
    <arm_group_label>Placebo treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatin</intervention_name>
    <description>12 month course of daily simvastatin</description>
    <arm_group_label>Simvastatin treatment</arm_group_label>
    <other_name>Zocor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-60 years of age

          -  acute SCI (AIS A-C) who are enrolled at our center in an ongoing surveillance study.

          -  use a wheelchair as their primary mobility mode

          -  reside in the greater Denver metropolitan area

          -  within 3 months of injury

          -  medically stable

          -  able to follow directions

          -  provide informed consent.

        Exclusion Criteria:

        - have any simvastatin contraindications including:

          -  drug allergy,

          -  active liver disease,

          -  renal dysfunction,

          -  concurrent use of drugs that cause myopathy or increase the risk of myopathy with
             simvastatin therapy (gemfibrozil, niacin, cyclosporine, danazol, amiodarone,
             dronedarone, ranolazine, calcium channel blockers, colchicine), strong CYP34A
             inhibitors (itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin,
             clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir,
             nefazodone, cobicistat-containing products), low plasma cholesterol levels,

          -  uncontrolled or poorly controlled diabetes,

          -  unstable anti-coagulation treatment,

          -  taking a statin in the preceding 12 months,

          -  metabolic bone disease, thyroid disorder,

          -  history of bilateral oophorectomy,

          -  current use of medications potentially affecting bone health including
             bisphosphonates, androgenic steroids, estrogenic steroids, anti-epileptics, lithium
             glucocorticoid use for more than 3 months,

          -  have received inhaled glucocorticoids in the past 12 months,

          -  pregnant or lactating women,

          -  women of childbearing potential who are unwilling or unable to use a reliable form of
             contraception.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leslie Morse, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Craig Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leslie Morse, DO</last_name>
    <phone>303-789-8970</phone>
    <email>lmorse@craighospital.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amanda L Turner</last_name>
    <phone>303-789-8757</phone>
    <email>aturner@craighospital.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Craig Hospital</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113-2811</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Morse, DO</last_name>
      <phone>303-789-8970</phone>
      <email>lmorse@craighospital.org</email>
    </contact>
    <contact_backup>
      <last_name>Susan Charlifue, PhD</last_name>
      <phone>303-789-8306</phone>
      <email>susie@craighospital.org</email>
    </contact_backup>
    <investigator>
      <last_name>Leslie Morse, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan Charlifue, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Berliner, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2016</study_first_submitted>
  <study_first_submitted_qc>October 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2016</study_first_posted>
  <last_update_submitted>March 30, 2018</last_update_submitted>
  <last_update_submitted_qc>March 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Craig Hospital</investigator_affiliation>
    <investigator_full_name>Leslie Morse</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

